
Liver biopsy in NASH by Prof. P. Bedossa
In NAFLD, the liver is both victim and motor of a multisystem disease.
Liver disease is not limited to the liver itself but has an impact on glycemic control in the body.
Prof. Tacke discusses this vicious cycle and how NAFLD may add to coexisting risk factors and is predictor of morbidity and mortality. He shows why this is also important to develop new treatment strategies.
Read MoreLiver biopsy in NASH by Prof. P. Bedossa
Liver biopsy in NASH clinical trials by Prof. P. Bedossa
Prof. Pierre Bedossa (France) exploring mandatory role liver biopsy plays in clinical trials for NASH and the need for a central pathologist.
Read MoreLiver biopsy in NASH clinical trials by Prof. P. Bedossa